Related Experiment Video
Updated: Aug 20, 2026

Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene
Donald Metcalf1, Marina R Carpinelli, Craig Hyland
1Division of Cancer and Hematology, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia.
Abstract:
Mpl(-/-) mice bearing the Plt3 or Plt4 mutations in the c-Myb gene exhibit thrombopoietin (TPO)-independent supraphysiological platelet production accompanied by excessive megakaryocytopoiesis and defective erythroid and lymphoid cell production. To better define the cellular basis for the thrombocytosis in these mice, we analyzed the production and characteristics of megakaryocytes and their progenitors. Consistent with thrombocytosis arising from hyperactive production, the high platelet counts in mice carrying the c-Myb(Plt4) allele were not accompanied by any significant alteration in platelet half-life. Megakaryocytes in c-Myb mutant mice displayed reduced modal DNA ploidy and, among the excessive numbers of megakaryocyte progenitor cells, more mature precursors were particularly evident. Megakaryocyte progenitor cells carrying the Plt3 or Plt4 c-Myb mutations, but not granulocyte-macrophage progenitors, exhibited 200-fold enhanced responsiveness to granulocyte-macrophage colony-stimulating factor (GM-CSF), suggesting that altered responses to cytokines may contribute to expanded megakaryocytopoiesis. Mutant preprogenitor (blast colony-forming) cells appeared to have little capacity to form megakaryocyte progenitor cells. In contrast, the spleens of irradiated mice 12 days after transplantation with mutant bone marrow contained abundant megakaryocyte progenitor cells, suggesting that altered c-Myb activity skews differentiation commitment in spleen colony-forming units (CFU-S) in favor of excess megakaryocytopoiesis.
Insights
Mutations in the c-Myb gene cause excessive platelet production in mice, independent of thrombopoietin (TPO). This involves expanded megakaryocytopoiesis and altered progenitor cell responses to cytokines like GM-CSF.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Mice with c-Myb gene mutations (Plt3, Plt4) exhibit thrombopoietin (TPO)-independent thrombocytosis.
- This condition is characterized by excessive megakaryocytopoiesis and impaired erythroid/lymphoid cell production.
Purpose of the Study:
- To investigate the cellular mechanisms underlying thrombocytosis in c-Myb mutant mice.
- To analyze megakaryocyte and progenitor cell production and characteristics.
Main Methods:
- Analysis of megakaryocyte DNA ploidy and progenitor cell populations.
- Assessment of progenitor cell responsiveness to granulocyte-macrophage colony-stimulating factor (GM-CSF).
- Bone marrow transplantation studies in irradiated mice.
Main Results:
- Thrombocytosis was not linked to altered platelet half-life.
- Megakaryocytes showed reduced DNA ploidy, with an increase in mature precursors.
- Mutant megakaryocyte progenitors displayed significantly enhanced GM-CSF responsiveness.
- Mutant preprogenitor cells had limited capacity to form megakaryocyte progenitors.
Conclusions:
- Altered c-Myb activity in hematopoietic stem cells skews differentiation towards megakaryocytopoiesis.
- Enhanced progenitor cell sensitivity to cytokines like GM-CSF contributes to expanded megakaryocytopoiesis.
- c-Myb mutations impact hematopoietic stem cell differentiation commitment, favoring megakaryocyte development.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic cells are...
Abnormal Proliferation

